These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19937689)

  • 1. Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease.
    Alisi A; Pinzani M; Nobili V
    Hepatology; 2009 Dec; 50(6):2048-9; author reply 2049-50. PubMed ID: 19937689
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection.
    Takemoto R; Nakamuta M; Aoyagi Y; Fujino T; Yasutake K; Koga K; Yoshimoto T; Miyahara T; Fukuizumi K; Wada Y; Takami Y; Saitsu H; Harada N; Nakashima M; Enjoji M
    J Dig Dis; 2009 May; 10(2):145-8. PubMed ID: 19426398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FibroScan evaluation of liver fibrosis in liver transplantation.
    Sánchez Antolin G; Garcia Pajares F; Vallecillo MA; Fernandez Orcajo P; Gómez de la Cuesta S; Alcaide N; Gonzalez Sagrado M; Velicia R; Caro-Patón A
    Transplant Proc; 2009 Apr; 41(3):1044-6. PubMed ID: 19376422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of FibroScan in clinical diagnosis].
    Nie JJ; Li J; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):715-7. PubMed ID: 19785970
    [No Abstract]   [Full Text] [Related]  

  • 7. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.
    Pinzani M; Vizzutti F; Arena U; Marra F
    Nat Clin Pract Gastroenterol Hepatol; 2008 Feb; 5(2):95-106. PubMed ID: 18253138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do not trivialize the Fibroscan examination, value its accuracy.
    Rigamonti C; Fraquelli M
    J Hepatol; 2007 Jun; 46(6):1149. PubMed ID: 17445941
    [No Abstract]   [Full Text] [Related]  

  • 9. [Should nonalcoholic fatty liver be considered precirrhotic?].
    Massarrat S; Asholt K; Schmitz-Moormann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():543-6. PubMed ID: 612027
    [No Abstract]   [Full Text] [Related]  

  • 10. Interpreting liver stiffness in the cirrhotic range.
    Bioulac-Sage P; Couffinhal T; Foucher J; Balabaud CP
    J Hepatol; 2009 Feb; 50(2):423-4; author reply 424-5. PubMed ID: 19070922
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient elastography: is liver stiffness in alcoholic patients all fibrosis?
    Balabaud CP; Bioulac-Sage P
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1309-10. PubMed ID: 19469765
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical markers, liver biopsy, or magnetic resonance elastography to detect or exclude advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Kayadibi H; Sertoglu E; Uyanik M
    Hepatology; 2015 Jul; 62(1):324-5. PubMed ID: 25546414
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage.
    Song ZZ
    Hepatology; 2008 Oct; 48(4):1351-2. PubMed ID: 18821615
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient elastography in acute hepatitis: All that's stiff is not fibrosis.
    Cobbold JF; Taylor-Robinson SD
    Hepatology; 2008 Feb; 47(2):370-2. PubMed ID: 18220278
    [No Abstract]   [Full Text] [Related]  

  • 15. [Noninvasive tools for the diagnosis of steatosis and fibrosis in patients with NAFLD].
    Castera L
    Gastroenterol Clin Biol; 2009 May; 33(5):405-12. PubMed ID: 19349131
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of computerized image morphometry for assessing noninvasive methods to detect hepatic fibrosis.
    Talwalkar JA; Sanderson SO
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):958-9. PubMed ID: 18774531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-invasive diagnosis of liver fibrosis: guidelines for the use of biomarkers and FibroScan].
    Vergniol J; de Ledinghen V
    Gastroenterol Clin Biol; 2009 Apr; 33(4):334-44. PubMed ID: 19346090
    [No Abstract]   [Full Text] [Related]  

  • 18. Science to practice: can MR elastography be used to detect early steatohepatitis in fatty liver disease?
    Ehman RL
    Radiology; 2009 Oct; 253(1):1-3. PubMed ID: 19789246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic resonance imaging for quantifying hepatis steatosis and hepatic fibrosis].
    Van Beers B
    Bull Mem Acad R Med Belg; 2009; 164(1-2):44-50; discussion 51-2. PubMed ID: 19718953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility and limitations of transient elastography.
    Friedrich-Rust M; Zeuzem S
    Liver Int; 2009 May; 29(5):619-20. PubMed ID: 19413664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.